Clinical Trial Detail

NCT ID NCT03678025
Title Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

prostate adenocarcinoma

Therapies

Docetaxel

Nilutamide

Triptorelin

Bicalutamide

Leuprolide

Degarelix

Goserelin

Flutamide

Prednisone

Abiraterone

Histrelin acetate

Age Groups: adult senior

No variant requirements are available.